Numinus Wellness, Inc. (NUMIF)
0.0207
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Numinus Wellness Max Drawdown (5Y) : 99.43% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.43% |
| August 31, 2026 | 99.43% |
| July 31, 2026 | 99.43% |
| June 30, 2026 | 99.43% |
| May 31, 2026 | 99.43% |
| April 30, 2026 | 99.43% |
| March 31, 2026 | 99.43% |
| February 28, 2026 | 99.03% |
| January 31, 2026 | 99.03% |
| December 31, 2025 | 99.03% |
| November 30, 2025 | 99.03% |
| October 31, 2025 | 99.03% |
| September 30, 2025 | 99.03% |
| August 31, 2025 | 99.03% |
| July 31, 2025 | 99.03% |
| June 30, 2025 | 99.03% |
| May 31, 2025 | 99.03% |
| April 30, 2025 | 99.03% |
| March 31, 2025 | 98.98% |
| February 28, 2025 | 98.91% |
| January 31, 2025 | 98.91% |
| December 31, 2024 | 98.91% |
| November 30, 2024 | 98.91% |
| October 31, 2024 | 98.91% |
| September 30, 2024 | 98.74% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.73% |
| July 31, 2024 | 98.33% |
| June 30, 2024 | 98.14% |
| May 31, 2024 | 97.36% |
| April 30, 2024 | 97.05% |
| March 31, 2024 | 96.14% |
| February 29, 2024 | 95.70% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 100.00% |
| June 30, 2023 | 100.00% |
| May 31, 2023 | 100.00% |
| April 30, 2023 | 100.00% |
| March 31, 2023 | 100.00% |
| February 28, 2023 | 100.00% |
| January 31, 2023 | 100.00% |
| December 31, 2022 | 100.00% |
| November 30, 2022 | 100.00% |
| October 31, 2022 | 100.00% |
| September 30, 2022 | 100.00% |
| August 31, 2022 | 100.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cocrystal Pharma, Inc. | 97.93% |
| Edesa Biotech, Inc. | 99.04% |
| CNBX Pharmaceuticals, Inc. | 100.0% |
| Invion Ltd. | 99.92% |
| ProMIS Neurosciences, Inc. | 97.95% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -80.17 |
| Beta (5Y) | 2.662 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 162.0% |
| Historical Sharpe Ratio (5Y) | -0.3304 |
| Historical Sortino (5Y) | -1.139 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 37.09% |